| 410 |
increased |
Carcinoma, Renal Cell
(MESH:D002292)
|
Adenoma
(MESH:D000236)
|
713: Increase, Adenomas/carcinomas (renal tubular)
|
| 409 |
increased |
stomach epithelial hyperplasia
(MP:0005493)
|
epithelial cell
(CL:0000066)
|
782: Increase, Hyperplasia (forestomach epithelial cells)
|
| 408 |
increased |
cell proliferation
(GO:0008283)
|
epithelial cell
(CL:0000066)
|
2 Events
|
| 407 |
increased |
cell death
(GO:0008219)
|
epithelial cell
(CL:0000066)
|
780: Increase, Cytotoxicity (epithelial cells)
|
| 406 |
decreased |
4-hydroxyphenylpyruvate dioxygenase activity
(GO:0003868)
|
4-hydroxyphenylpyruvate dioxygenase (rat)
(PR:P32755)
|
766: Inhibition, 4-hydroxyphenyl-pyruvate dioxygenase (HPPD) enzyme
|
| 405 |
increased |
|
tyrosine
(CHEBI:18186)
|
775: Increased, Plasma tyrosine
|
| 404 |
increased |
|
papilloma
(MESH:D010212)
|
779: Increase, Papillomas/carcinomas (squamous cells)
|
| 403 |
increased |
cell proliferation
(GO:0008283)
|
corneal epithelial cell
(CL:0000575)
|
778: Increase, Regenerative cell proliferation (corneal cells)
|
| 402 |
increased |
inflammatory response
(GO:0006954)
|
corneal epithelial cell
(CL:0000575)
|
777: Increase, Inflammation (corneal cells)
|
| 401 |
increased |
cell death
(GO:0008219)
|
corneal epithelial cell
(CL:0000575)
|
776: Increase, Cytotoxicity (corneal cells)
|
| 400 |
increased |
membrane hyperpolarization
(GO:0060081)
|
|
763: hyperpolarisation, neuron
|
| 399 |
increased |
chloride transmembrane transport
(GO:1902476)
|
chloride
(CHEBI:17996)
|
761: Increased, Chloride conductance
|
| 398 |
decreased |
|
population quality
(PCO:0000003)
|
765: Decreased, population 1
|
| 397 |
increased |
chloride channel activity
(GO:0005254)
|
glutamate-gated chloride channel (fruit fly)
(PR:Q94900)
|
2 Events
|
| 396 |
increased |
endometrium hyperplasia
(MP:0009092)
|
glandular cell of endometrium
(CL:0002656)
|
772: Increase, Hyperplasia (glandular epithelial cells of endometrium)
|
| 395 |
increased |
synaptic transmission, dopaminergic
(GO:0001963)
|
|
746: Increase, Dopaminergic activity
|
| 394 |
decreased |
progesterone secretion
(GO:0042701)
|
progesterone
(CHEBI:17026)
|
749: Decreased, Progesterone from corpus luteum
|
| 393 |
decreased |
|
Prolactin
(CHEBI:81580)
|
747: Decreased, Prolactin
|
| 392 |
increased |
|
Luteinizing hormone
(CHEBI:81568)
|
2 Events
|
| 391 |
increased |
neoplasm
(MP:0002006)
|
|
745: Increase, Leydig cell tumors
|
| 390 |
increased |
Leydig cell hyperplasia
(MP:0001152)
|
Leydig cell
(CL:0000178)
|
744: Increase, Hyperplasia (Leydig cells)
|
| 389 |
decreased |
receptor binding
(GO:0005102)
|
testosterone
(CHEBI:17347)
|
743: Decreased, Testosterone binding to androgen receptor (hypothalamus)
|
| 388 |
increased |
|
Thyroid stimulating hormone
(CHEBI:81567)
|
2 Events
|
| 387 |
increased |
hyperplasia
(MESH:D006965)
|
thyroid follicular cell
(CL:0002258)
|
2 Events
|
| 386 |
increased |
hypertrophy
(MESH:D006984)
|
thyroid follicular cell
(CL:0002258)
|
2 Events
|